Organon (NYSE: OGN) reported Q1 EPS of $0.71, $0.12 worse than the analyst estimate of $0.83. Revenue for the quarter came in at $1.46 billion versus the consensus estimate of $1.52 billion.

For earnings history and earnings-related data on Organon (OGN) click here.